DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slipped 1.40% to $11.98 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 0.88% to 26,635.22 and the Dow Jones Industrial Average rising 0.75% to 50,063.46.
The stock's fall snapped a four-day winning streak.
Corbus Pharmaceuticals Holdings Inc. closed 41.73% short of its 52-week high of $20.56, which the company achieved on October 20th.
The stock underperformed when compared to some of its competitors Thursday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 0.62% to $6.39, Fortress Biotech Inc. (FBIO) rose 3.14% to $2.30, and Viking Therapeutics Inc. (VKTX) rose 0.03% to $31.71.
Trading volume (217,857) remained 47,095 below its 50-day average volume of 264,952.
Data source: Dow Jones Market Data, FactSet. Data compiled May 14, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 14, 2026 17:20 ET (21:20 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments